Opportunity Overview

Belantamab mafodotin proszek do sporządzania koncentratu roztworu do infuzji 70 mg Belantamab mafodotin proszek do sporządzania koncentratu roztworu do infuzji 100 mg Szczegółowy opis przedmiotu zamówienia zawiera załącznik nr 2 do SWZ. Oferta dla swojej ważności w danym pakiecie musi być złożona na wszystkie pozycje. Zamawiający nie dopuszcza składania ofert na pozycje w ramach pakietów.

This Poland Pharmaceuticals opportunity is one most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agency	Wojewódzkie Wielospecjalistyczne Centrum Onkologii I Traumatologii Im. M. Kopernika W Łodzi
Country	Poland
Category	Pharmaceuticals
Published	September 08, 2026
Procurement stage	Request for Proposal (RFP)
Response due	Not specified / rolling
Status	Open — accepting responses
Original language	Polish — members read it in their own language
Official source	View original notice
Last verified	September 20, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Poland market overview →Browse all categories →

Related Opportunities in Poland

Poland – Pharmaceutical products

See every Poland Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Poland Pharmaceuticals intelligence report in your inbox

A personalized report on Poland Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.